{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.2-dev",
    "document_metadata": {
      "copyright": "Copyright Â© 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "Clearance systems in the brain-implications for Alzheimer disease.",
      "version": "1.0.1",
      "authors": "Lingling Xu",
      "description": ""
    },
    "namespace_url": {
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mesh-names.belns",
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "GFAM": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns",
      "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns"
    },
    "namespace_pattern": {
      "DNSNP": "rs[0-9]+",
      "HBP": ".*",
      "TAXONOMY": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {},
    "annotation_list": {},
    "path": "tau/tarasoffconway2015.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "amyloid-beta polypeptide 40",
      "id": "2ca2eb795438fe9e0f24c1e9d332717de5e344ddfee00ce8df89c5b901d85db5994d6ffd383e40a90bde264f33e75b220476b3de86c89f0658bf281c872f0bb6"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "amyloid-beta polypeptide 42",
      "id": "c2da54109c90719396dfdfb558be74582b8522863849a50f3f5029b7d60f4d53df3cfa1a97b787e760a2f74ea1f74012eb49273beeded42a2873d788953b4a13"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "amyloid-beta",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "amyloid-beta derived diffusible ligands",
      "id": "bb1bf00d89b855bbc846286bc0389eba22194342acf023f66bc324ceacf0ba483cee9dc67d56822bb7efa028804229cb820f4c45346b8131ec4cc58b8ff7f06a"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "amyloid-beta polypeptide 38",
      "id": "46a4ce0633f4f9a8f2027af85a8aa992e17f3a7ea7cc353dea0c4631fb16a68ce2eede28fb739625039bd9884aa36a71bb1abd38048e61a7ec5e3cc5e10e8889"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Blood-Brain Barrier",
      "id": "7fca36d75c7eb80fc4d9a266e0495874263cd3b244d25188e46c307b9462dc9cef157c6b084fffaf555bd26c66e99ec1130c4a221c64e4ab1fbee5c425fb3c4c"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Cerebral Cortex",
      "id": "d570f84dde08e8887b0ba3cb15f79f0f4378d9c7417d64d2a363380e917313da6df600a00c005cef2a697249feaeb07da95f500476083923a8f77b9caedb6e35"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Cerebral Ventricles",
      "id": "1d556e1bcaab6495479ace45f2ebb3fef9d0a70140fb7d107e0637fc07b51e11dbcfc2ac7e37939a4b57643b3ea73649b680ca9ed6c2d3186bf968652b432a4c"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Cerebrospinal Fluid",
      "id": "a811f10ece68566878659d2563b4668afcf5e8221fd0c1da7bee64007396636376aedce3f5768cd57307b1a1ac8fee59d4c3f5b201ed2dfe81ab8f11f0623ed1"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Extracellular Fluid",
      "id": "4ce2785483ebdc80336672a9f877f428736f1e6d18186088bc9b1dd4df9659367d9a9bd9a3686437e1bb55680dc373db5426a9c75cfa9ae1d7e35ac195dca724"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Muscle, Smooth, Vascular",
      "id": "2f74808c06998815c617b74db27a42a621e1b7325a8d74071c396ab8d0b36feaedd8c145788052976d5a2e465013f3c787a11d077547602aa5658fe1df1818a7"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Prefrontal Cortex",
      "id": "a46eedf8b35d8b1ceb910ec59f492474dbda49456c714b84901d2f45a89624e05a4cf1cb783df91f56f184d848d9155e8f910bd96a89aababd480d4d61b72007"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "White Matter",
      "id": "2955560f6e70748b84bd1dc261fe6a5ff651e69b646fec26ac6cf206ee733b8dc8b27ccd791f9c913426feade19fc741959adb2902094ed7c502363505fbb02e"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Astrocytes",
      "id": "fde64edccc2d2516ac85472bd1b91641459a78f34e06f497636f2c401c2df220b9a929108658f0d9c4b8091c3bb917ecf96b52133a312a439d8370e834a2ef91"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Brain",
      "id": "9175288a6c7b6ef9b1d5b27898a9df1220476f7b15df878df555ca1003f86131d9293d04e396275cf70eb020d39ca118c7325524f243d1b6cdd28f86130be6f8"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Endosomes",
      "id": "744d7b0c6b61e547a898cd49f96d58fa40e339d76b7f1618b56299ee476380752928a20087afa1c955be4376c1a50fdbefaec9fd59a2f190f2d1e3cfbb36715b"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Insulin",
      "id": "f443e2f941656dccbc0086f2f573d9c3c346d1bd37a3f09c96cfe8f6ecccf0c98b7b248d184349237908bf59e4c95bf12f4ff8cd383e1335ec48431477e52b3d"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Lysosomes",
      "id": "5bdc4f001303328428ac361a58c2c115c993a633bc703abff8f4f5a892f1674a1f4612a541e30ab897fb789fa8698fd11eac180236847f483cec9bc7ca9daa45"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Microglia",
      "id": "02b5c9d69be012bcb43f05ec21f3168522e7cb682e90a7956b198540388c2652cc63707a9400288a6cf9ac7fe288615986eafce8e609e0871e97885e133245f9"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "glucose metabolic process",
      "id": "6681cf02278d39bd743eb5de75ec62487ae3b5c20d67d093d8eac248b88f7f481874541876ec7942d3430b054ebe491b1737e811ade8aad646f60cc638344ac1"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "import into cell",
      "id": "7e313069cd722230556c628c74de82390f72c8380d49804df0c4e58d07547b1f58c94fa21ed84ae9bd8a81fda8fa9f17e14500659ca3ca17d1e5cd3d30954cbf"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "autophagy",
      "id": "f1a3202be460e565f65c1445ee061e99f63cc05f9ab70c5d4d8d93ba180d6a94f65cb8d1ac6c5ba53c0a4d2e153db32135e6a0bffcfdfd4d84e6727594a70b0a"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HBP",
      "name": "glymphatic bulk flow",
      "id": "6f097a26187d848e67729d744ba4a49229a10a5f8cc4f7704ca1ec424c9cd3d6665cf036a0d767f1d32b98c0883843435902bf1bb11d72bd0d4f6f2f448e9e2e"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HBP",
      "name": "perivascular drainage pathways",
      "id": "301aadc1b6b4ad5cc8a33362a3717728f3cdcf8157203a3bd323411166ac3ee0930163cb9534e8db2edd7b9e193a8f81fb354bd70a4bfe68c8fcdbee36b4cb60"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Oxidative Stress",
      "id": "32bd3ab5e8a3a26be3209856c88741f0f0e2dff98d2587599a6a21b0f4793c5d8feb1194ea2166cf3cece076e7095530b116270e6655bc8feb35a437fda42cf6"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Endosomes",
          "id": "744d7b0c6b61e547a898cd49f96d58fa40e339d76b7f1618b56299ee476380752928a20087afa1c955be4376c1a50fdbefaec9fd59a2f190f2d1e3cfbb36715b"
        },
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Lysosomes",
          "id": "5bdc4f001303328428ac361a58c2c115c993a633bc703abff8f4f5a892f1674a1f4612a541e30ab897fb789fa8698fd11eac180236847f483cec9bc7ca9daa45"
        }
      ],
      "id": "046ccf14077c4ea6d5edbfb4b2091831164443c080066de56c0cc343a8270a4e81cf45056f618f4858b5e0f5d93390a3a2295f01850dff94910b3ebdb1414263"
    },
    {
      "function": "Gene",
      "namespace": "HGNC",
      "name": "APP",
      "id": "b0c972ce318230ec034b96a29f2c9eb3fa32c869d5e9c638cdcaa908769ae5ff5cabc371877c4355af3727c7f5baf19cb604ed0283769cdb29d3bc43f375dd43"
    },
    {
      "function": "Gene",
      "namespace": "HGNC",
      "name": "APP",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "?"
        }
      ],
      "id": "1866bebf4b1fa1c88c3a165a5c7f2f22e87c268272d835dad5bf43fc435a1b19c1bfe3490ce974f1258653a3acfa503df1c1c01d81ceca921044b887bbe7622c"
    },
    {
      "function": "Gene",
      "namespace": "HGNC",
      "name": "PSEN1",
      "id": "a41476b93b2676ab2057f762b596676213ddc3f1c34b7d8cd614e03d06776bdb81f3f29884a6abd0ca53b180983c74565339434b096f85b668798185abc92501"
    },
    {
      "function": "Gene",
      "namespace": "HGNC",
      "name": "PSEN1",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "?"
        }
      ],
      "id": "c25ff74c45df969be8a565ef6294983772d87355c966b8bb9d4b47a5c925c28241f5ddddaa655327219fffef72637a27ff332b8a487cdd9b0632f5f9ea2c2b4e"
    },
    {
      "function": "Gene",
      "namespace": "HGNC",
      "name": "PSEN2",
      "id": "711eeef739154f7765bf6718ebb2b0a136fba0d6c4cf159d84e8fc611f78f7ab135a2facaffacc0e696fcb7404169eb3146bd41249a97caf0f5a84b5e39e0bb9"
    },
    {
      "function": "Gene",
      "namespace": "HGNC",
      "name": "PSEN2",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "?"
        }
      ],
      "id": "da95db32988729d4544cec084b6f6dd153a78d6e9baa2aaaab7dfd579e1c7df8d14017c3a9ce2fc814034bd248484f2cff01c81e0f789fe8452c5c61e7fa6944"
    },
    {
      "function": "Protein",
      "namespace": "CHEBI",
      "name": "amyloid-beta polypeptide 42",
      "id": "28b313e4c8862e5c5e4c61250bc7fb4a27198024ddb8bedf748b82ded0c7d1ed6d616e8cb18a27c8729f80d6e3b6a70afe480b0f772cccf217c9e3f15aa72b07"
    },
    {
      "function": "Protein",
      "namespace": "CHEBI",
      "name": "amyloid-beta",
      "id": "445dc344bafdbea7922acd17e48493d550b66d8e78ab68391e52ec7ebb4b2d37050ab6a3829bff786c81d36a8dcc7835a33589e2e841cf45fd2d33728b58c0be"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "APOE e4",
      "id": "a519d6630bc8e246f2e2604c283b9bad94ea08e43b589ba0c7b579cd4dd7776fd102b8bb0f102104720c312573c9bbadcf691c420a26bcaf53f05359810784c3"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "tau aggregates",
      "id": "30e7b841a8ceabb28646012129802c27016d53c9b269ac5ef6b577f05547377fc902cb44854f4383613fd9efb7d2a99a415cc38d00b24a1e4d0a3bf2514fa6b9"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "A2M",
      "id": "767453c0e582c058dac430a0deece91b13bfc50b50e5a6c97522ee77fb743f5785fc048d21a776c0a40fa9a7c74b141ed4957aed3bc8608e8d82fc2938f4f674"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ABCB1",
      "id": "f182bfc429f9a27cfb170568ab4bacc12054ec415fc936a5a519f5f6d84edefa0ac5948d5280c8b781d25268cce5916244b40674c98d90ab06fb9186ee263907"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ACE",
      "id": "f350a57db6e8966331dabc421f283313beee8a91955858c65b4c534ff9002e731350545899874220dfaf84da2cd96ab01fd311c5803dbae47559f58a0d4c819e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "AGER",
      "id": "7e397a005d17551ff46539ab6c2a5709d61f6e6a34c53dd914d2390a36fe3641cb438c1f1e5a08095695db19ea9e931449ec027bd08e3cdfafaf5acad2a74f4d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "APOE",
      "id": "b17ad2f45c20f323d56bf6d806eceebc45de815de6578a61f820329d5bba1059af52aa63bfcba2bea3b71985bc404e5fc1bce130012d3c58f3a39023923ffb43"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "APP",
      "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "AQP4",
      "id": "0606ef8ed985759822e11ec738204b0ab3ff978e467bf381822f25b4eb41bde5af34489f01630a3a0048d02371239aa624807dd6a76b3a7a82476bbfa2e595cd"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "BACE1",
      "id": "88f17e7dffb6947c01414f79e5a3bb9cdd3e932c355af7f0c8907d2b5d07742883eaf63866fe7fc938401ce0c366856fd5e306f324e6c1f474c1a984c8e46a51"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CLU",
      "id": "07e2cc76a66ad6ba376cd46edc3b890f433ef1d75993ca6eda01a42426ce3c571a087492b563b89e1dd47f5378d37da4da58910b56486eda98cfc86214300387"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "IDE",
      "id": "ef40c2282a9443979f4a3a31bbd42f8d713281448c6551e853da09d253ebc0bfe8c17ea3042707bdf539f2c0921898b22e8ce3af7a86ec859c803801af7d8ce5"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "LRP1",
      "id": "aba7c0e940b52c981e1639b0cd828988284d900b0893f15eaf8ed67a6809f7be343505b702440a71be4c53beb05bee18c776c6beeea2ec601f7a3144a8eb7547"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "LRP2",
      "id": "89d1a5e992b78408a5efda6677cbbb569683a12ea085de637b250bf18f509847498b42a25cce766e40f6ee45e0ccc03cf707c4cab7a57e353d7d7d87f53aef0c"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MMP2",
      "id": "34870a1cc27321004b2000a39f1f5114ed7aeaf2c939e9883ca6efb42490e30644274705c14d5694c3ce84cf38c0824d8c1c609e1c794efa7f1d441be6c8002b"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PICALM",
      "id": "1baf71acaa1a0777092dead04c4827cd5e184984ae77050f14b6ac758a7947e13e5f30bc2d9d5b4abff5ca71ea6f8284279e4edb12c870ab4fbb7deaadbdedb2"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PPIA",
      "id": "1f1cbcab7b1236a2d7bb27931a15021326953b37f24ffe0e28f30cc887629cb6e3368e0cdda884a2829aaef887e9fc5e5c7749348f6991c8d470943a3d71fb8d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "TREM2",
      "id": "0c92a01567d99f7f796cc73d224c09313a1f6f09cc8cde12b94c98269a76a2249417a6eb407ce2afea5c6657fd29c14793bdf36a80dc5f37df676e2972a8ee44"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Amyloid Precursor Protein Secretases",
      "id": "5e3f73cfeba08ee1f4cfc1134aab3bf3c128c772465fe3083c3f2b912458976378201d5a1ae962000448481d716693ee1f9e4ce2452a8dd466233364130b1551"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Cyclic AMP-Dependent Protein Kinases",
      "id": "ee9a8850def1c6c0a93482d8d5c04086543f33fe5ab23c7c0f667149ea6d1b7b2eec7dfa67785a7199d05fff966640fc48cdd54d49b47adf5af492c9addf8337"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Endothelin-Converting Enzymes",
      "id": "247358eb4a355850ee0d074c5ac484e6b6f2c252efc257f6272a35846b4fae5eeee24400347f72fbda573f40133f5ba651f9e72a16ace410e4164fceb950429d"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Glutamate Carboxypeptidase II",
      "id": "933c7389b0d9e0008992d915ec37a644b416966cc50567dd869ce450ae3a9911fc444de9be1cb47a9a67d63f5277d216ead52648223372414ec5918a066aea6d"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Matrix Metalloproteinase 2",
      "id": "1e1b3bac73d7ed6f90528457d1e3cd902c5262c594418c86080a36d67b06af93b42b78b6efb0ef58daf4387f2959035918ffe2526b72cc016ea94370a72ee5ad"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Matrix Metalloproteinase 3",
      "id": "2125793a0f03c4a0916504594715d40250e1fbdae2b68edd01b11b413a3b189ef6dfc2d4be0ac763b6b48962bcbd66573ae75866dd2253a95d792a5603b029e4"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Matrix Metalloproteinase 9",
      "id": "eaa7d451e92dbe5269e266176a48fbbe45746aac0c0e56601a9eead5a9846afc14ac5b3db4bc8c44a54a861e77619424f7616b0f10d35f8ff74cd76d181ace88"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Tissue Plasminogen Activator",
      "id": "64076a9c1be5b93f811b9ed11065022ab339c31e256f843b2c6348fd5f8f20864d873cdddf580ea7fa39c4a7ac853e06b35661cf8daa82f87d58d1c40b223402"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Calpain",
      "id": "740d3413dc934649da1bf44e02f9cd18e771bdf56c0832ac8c60c2dc8f335fe12848d079804bb8ad7e18ad7f1a7198b3024cae5664420eb631807bd265b46ce7"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Cathepsins",
      "id": "bf9c96a5ea45386c44ce70307012436aff3634273e011b220569c5bbf3bd967826c480171b2c69207c314744643acfa8097b4f3000e8ccb0c809f726fda4031e"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Fibrinolysin",
      "id": "8c6234a6db71210d249e5a14c46134eabd0f5311cdda81c14330d30864f9091e7fa1970de454efdf6778591a8ba08512213c9418ef28fb443427f7317b64861d"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Lysosomes",
      "id": "6a67ef1f8b34b662d490a2a56403bca2129d367a02e80ad665b20d1cb9c721ac1be0d9696b44752749b4efbc40351da4587ceb12b75f104c220ee665c2dd7eb0"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Neprilysin",
      "id": "0e7722ab470c9a96ddebac00cf08bb2e26bcc5caa139dee9fbd18d7fb9c4e47d27e9cd7d194b1cc8e9bfe1edf3e6ef2e434940d908c6232ec63bcee8e9fea4c9"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Ubiquitin",
      "id": "2f0a325c62f280e386b6c632628b58a2efabfe8749e16c9ee21885caaba438b896e8c9911df856db4afe9e661ee5ed8604b0d888a011541f3825b6a8b8102dbf"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Aqp4",
      "id": "082db94874aa8d6e18075fbb0aa44d5f0a06ad523abe26ec4bc8044c26518be1c61958eeac94f36cd2f6a469c9af23fdf2c46ac4f9cbf271f9ed2e2a4dfa6fc3"
    },
    {
      "function": "Pathology",
      "namespace": "HBP",
      "name": "high-fat prenatal maternal diet",
      "id": "d9a605254b49e16ec13c852d45f2f7d4077cc43e8267efecb683004bf8bfb89d8315c55508fbb2eb351c1a3ccbb9a843be036ac6f33987ee534c2d8ab6ce02c1"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Alzheimer Disease",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Brain Injuries, Traumatic",
      "id": "045bae6eea134b42537774fcd702c7450a66a9f19fedd90aed63fed01468978b1449afeb8e68a5bf609df87bb9d2bc4613280f3a7225911fb029ca78ab2f02d7"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Calcification, Physiologic",
      "id": "e290ac4c69637aac90563227faa470e3254f70cdf308693e6c5514144b126343af632e1c6d8772866d13dc8189d967cb4ed97502dc968e8ff344d14ec7faf28c"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Cardiovascular Diseases",
      "id": "6b78a50fee2c5ce47c0ffa42f440a233340ac685cc3efa7b2c06bdcbdbfa4a530b1c0c9dbbf219fafec8fb740f76f6df1420f681741f05cbfb0fc544877b1d67"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Craniocerebral Trauma",
      "id": "224b625762d84b60f7c062c88d320f132bca3da768e70bc9cccc58e00606baacec598b6253d534c2c9caa2bdc749ea5c5f4c9294af04dbc9849fbfbe42b9fc2b"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Diabetes Mellitus",
      "id": "73670e71c663101822489d1ed3c9a4b898cbc242a91a84a186809a6dc709d550b20ae5ff2787dfb44fcb58e48091058220fe6afc80b8b21f5092b540d5cde8bf"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Pick Disease of the Brain",
      "id": "7917fa738d79ac0c2819622046fe373e477ef318b8693a75fd3871cd7df292afac3f425f2393f72cbb2813ca81347b925f64a4b874ca7d64c778c9d6e189eead"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Sleep Initiation and Maintenance Disorders",
      "id": "25764b1e77d52d7eb25076572b7149d58d68f9c66e224217803fa9b282137f254000c7688736ed7073bb214b1a7feb177cf137e07b70d30c4503ea221ade4232"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Aging",
      "id": "f82bc55a3ca4dbf1bcf4dd8e936186a3dc2485d4af0293d8329718469e9302f6d84c17f19744ca4aa61b97929530a10335ac8403503d590aad50b8ed831935ab"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Fibrosis",
      "id": "0b1c5f160d153dd4c47fbf2e5fb19c565dd3052f4683c97f0ae5cedde1fe663502b22f7c5871409f17f0b9f28cf0a76fecdd7f5a55aa89be50a95a4775225db0"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Hypertension",
      "id": "d7bbfbcdb198ef3b72728fdf0b7777e015941a545078e2440fcc0c379e5132750dc90a45a2f159ec4d9a2c01d1626f108a0d3a782fcc7b59b4c00a945291a4a2"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Inflammation",
      "id": "3196cc4c6a20279c822cae925a9b271d0224f2c8d468e3069a3ee460662be286b61db2f144c550686a9c624e58af4ffa7570f4f2384e1cb8ee40496f8cb3fa5e"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Sleep",
      "id": "b47120a52dbd00d4a798376862035e0494e6fc734e660b9d0cf23264242a328e286f61fb5d9f55ba7d96fc5eb45319216a35e36eb95034433cc3e2e26947ff6d"
    }
  ],
  "links": [
    {
      "line": 67,
      "relation": "increases",
      "evidence": " Emerging evidence suggests that AÎ² clearance is impaired in both early-onset and late-onset forms of AD.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 41,
      "key": "069e4ea171c1b1f764dc1e4129afb7b92b18099f08eacda4d8a16fd78dff1e621b01efbfa83de71d5ba96732962c07ecafaf5182e8d6cf1322a22b303f244cb3"
    },
    {
      "line": 87,
      "relation": "association",
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 29,
      "key": "9bc53b0f4be2e068f0b9b13c74e14428da7b6bfd52ec6d05cdafaafed8690344c9256efe53f414bc46fd75316112e56e246b8ceba54e8e230ed4bbc0a662996c"
    },
    {
      "line": 88,
      "relation": "association",
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 31,
      "key": "6c90851f4e9166fbe1bac560498489e7112a2f8a0b1656880edd5b54ea28597d15cf0696c409bd5469027539157117ec756d35763126157052f6b9b5969e2e32"
    },
    {
      "line": 89,
      "relation": "association",
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 27,
      "key": "d8b0ba6de269e8992eb0872425c387af4bebd99c51016c29f46ceb10b07bdb5eb64f57f0682c208d95896f59691af755c02addff9b6402686371cbd69cc9c5c1"
    },
    {
      "line": 92,
      "relation": "association",
      "evidence": "Various factors have been reported to positively and negatively modulate the risk of LOAD. Specifically, the greatest overall risk factor for LOAD is ageing;",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 78,
      "key": "1f0fa42166e9d09a75b7c96b2a4e3903ffab8316de66482e9030a34962459bdc0abe1008759f5397bb0b4a349b3a68e82e0b7a11b65d48e5e436768bf132dd0a"
    },
    {
      "line": 95,
      "relation": "association",
      "evidence": "The strongest identified genetic risk factor for LOAD is the apolipoprotein E (APOE) Îµ4 allele (APOE*Îµ4),",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 34,
      "key": "822ded059f479a5e0d16deda2b6db464f6f97845f5cd639c2feebe17c0c9a8824b66448de9fce9d7c474527ab365005e0d616597250d10a638b6966ddb2ddc9d"
    },
    {
      "line": 98,
      "relation": "association",
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2),27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).28,29",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 53,
      "key": "58247d9ea014989211e3e05679c03641edba8f16086c66b5462706abc4d9204b610b27a265aa572446f276633eab192b127fee03896edbefdc2ca11efe475c0c"
    },
    {
      "line": 99,
      "relation": "association",
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2),27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).28,29",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 44,
      "key": "0c6a2ecb180a9c84e617fcde5f3f615b5d2e6b3e3e60414ee0d7f82c1bc81e16ebff9fb758125dbab4565a04e4fe6b7a48b8e2a4d82bfe6e5cc4e8f0f1f99c19"
    },
    {
      "line": 100,
      "relation": "association",
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2),27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).28,29",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 51,
      "key": "a5c6ed02246d85c75c44acfc9a14a48e718b6670526f6389538326b59695f1ba8fb8f72104ee329429365b0046d51edcad1e91a2debfb2e23142861a84737ca5"
    },
    {
      "line": 103,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 73,
      "key": "af8a6fa811dbeff4c1158a2a6657a42139c02966519e09760bc943d39647b160ec99eb82c0936760281d1bebeb9f1f9b5f8be81396d03286c1c8c48ea863d725"
    },
    {
      "line": 104,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 75,
      "key": "f412c6d6d62cbd9c900cbfdbcede0a476c46b036540065d2a1832a70e9efbfbc556675e917cf118ca745c8d717643be7043546fa1905edfae5c1a632cccbbbee"
    },
    {
      "line": 105,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 80,
      "key": "5fdb79d9db0c30bbf487dfb5ff86b9256cbc388180eefe1e4aa4eb321e4fdf85713c7110c213605ebf900b413319831014bd903b7910203cbea0b0b708c4bf19"
    },
    {
      "line": 106,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 74,
      "key": "28491bb04b39326261c7fdd368631ca5f2f70a664ae73503733533f05299440674d78289ea746e07ae806f9c358ba4ddab4c78693ab41c2410a03944118e676a"
    },
    {
      "line": 107,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 77,
      "key": "9b777f46b9e54fb809a1d524c656b6c18fc33bd0410e25e8af2e9ac50d5971540938fc254f4829ae70ade3296a6a90f8739d35bf867fe1b5e977e9b644726fc6"
    },
    {
      "line": 110,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 76,
      "key": "f32d908331c5010bf006900bf33bc4e118faf08568d4a9ddcfe57d8826d2b05fbc88b107a771ea7f46a52cdc6f72d625f234cd43d691ce669ea39419167350c1"
    },
    {
      "line": 111,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 11,
      "key": "23ed3521471ce0a0cb78dd69c1fcbbaee8899a863965d7a7e42c20fd466d24f874bdb7115eb3d0759731286dce6b3577ddd8d6f3da7423371ed0f7a30c29a38f"
    },
    {
      "line": 112,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 6,
      "key": "1de681990a1dbbfd6c81da1296820e8536e3b1437ad992ac988eb7c926e4c6919d0cc7fe840e8ed43e0baa9dae7bb5d6442a6a2458c5389d5ef570bb41551aa9"
    },
    {
      "line": 113,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 7,
      "key": "3e3441399ac76c256a432bed2853b2e6f120d3c09a51db3e79c1c0e4b66f95c69fdb5644487c3324eede8b0349634c26073c50347ca94bbccc9a23df7968f536"
    },
    {
      "line": 114,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 12,
      "key": "d4efd129bfc744d7f4bdd06549bee6e330895c4da70cb607e795b73f2a115d73207f8c0109881cbf7a6494fb46e831d16d4f389d9d940f03a47339fbd8a040b1"
    },
    {
      "line": 124,
      "relation": "decreases",
      "evidence": "Recent advances now enable several AD-related brain changes to be detected in vivo: 18F-FDG-PET detects decreases in glucose metabolism,45,46 and MRI detects brain atrophy, as well as diffusion and perfu- sion abnormalities, which are most prominent in the vul- nerable hippocampal formation and cortical regions.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 19,
      "key": "a1487449f4158704968a51c50ab162b7f521e68c4011b6f308382b13fb871617452d1bc99864c201d1ae7ed819305c5152daaac1c6e3bd09e1d834a0c9a385d5"
    },
    {
      "line": 125,
      "relation": "decreases",
      "evidence": "Recent advances now enable several AD-related brain changes to be detected in vivo: 18F-FDG-PET detects decreases in glucose metabolism,45,46 and MRI detects brain atrophy, as well as diffusion and perfu- sion abnormalities, which are most prominent in the vul- nerable hippocampal formation and cortical regions.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 14,
      "key": "20294fcddb2cba2f1a40288907800a98046c8fa767435008c222936baedeca3bc5b8dfa1100f1fa7a943c9eeb3df444eac3c8c43cf55e5267a3d91733fa7428e"
    },
    {
      "line": 141,
      "relation": "association",
      "evidence": "Given the size of AD-related proteins, mono- meric AÎ²1-40, AÎ²1-42 and tau, should be able to pass freely through astrocytic endfeet clefts at the glial barrier.72",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 0,
      "key": "7a705ebb8dabb1149610ed07cdf84da1c164cd7eadc87cb2f8b584933de2ec2adbb2755db134f7a490e5d87de495cdd8d65b8f6ac10ed786c17aae90658e86dc"
    },
    {
      "line": 142,
      "relation": "association",
      "evidence": "Given the size of AD-related proteins, mono- meric AÎ²1-40, AÎ²1-42 and tau, should be able to pass freely through astrocytic endfeet clefts at the glial barrier.72",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 70,
      "target": 1,
      "key": "9b978cab8a0968bf95296209bf7f2659e4d01b35734d98f1f669cdbbc99f96842fea75206a6618dda5747adb5b3fb76bb62348025e47145e4627c752cdc69a1b"
    },
    {
      "line": 178,
      "relation": "decreases",
      "evidence": "First, expression of neprilysin is decreased in AD,126 especially in regions with high AÎ² loads such as the hippocampus and temporal gyrus.127 ",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 70,
      "target": 66,
      "key": "0c4ae4af09d2d5e4204606b4639df41db6904d51a33154b597132c15564562f93d56a62cbea597fe486805181b616c2112bced229fea741ff544d2e1dea534c6"
    },
    {
      "line": 181,
      "relation": "increases",
      "evidence": "Although overall matrix metallo- proteinase 2 expression is increased in AD,58 its activity is reduced in astrocytes that surround AÎ² plaques.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 70,
      "target": 50,
      "key": "e63c080182fc0778c44bb64b545771ebf3c4a71e5016055119eeff3d2b7615d72a7a47b6d9ea9c44d4a868ef1cbd299fa3eb4137f1525d79265703c0e36ddebe"
    },
    {
      "line": 216,
      "relation": "decreases",
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1123 and ABCB1147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 70,
      "target": 46,
      "key": "f9c210361d1077097c999aa038152a01f09647fe33dc8e28b0cde011c3b88bf59df416f7d536bd721d5dba972cdb0e408d4687922756b972f2866c7d5c8978d6"
    },
    {
      "line": 217,
      "relation": "decreases",
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1123 and ABCB1147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 70,
      "target": 37,
      "key": "d93cabbfee9e142e07643b5babd96408199706066b5ba852ad5f5cc5ac9266aba2e4e49f085178eb702251864b2eb1d493da10237c767f1119f04eb8c30afa7a"
    },
    {
      "line": 218,
      "relation": "increases",
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1123 and ABCB1147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 70,
      "target": 39,
      "key": "ca6e4c4058866f97d1bbb67cd69c27b8c3d330cea204925bad83c43c6002b9da06a32493ed9dfac45341995a636b9d5064a133d66a02775e903d9a786a6572f9"
    },
    {
      "line": 261,
      "relation": "increases",
      "evidence": "In AD, the choroid plexus undergoes many structural changes, such as calcification, fibrosis and AÎ² deposition, all of which can obstruct CSF production.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "source": 70,
      "target": 72,
      "key": "bf7530898642a201a80195e1ec3bb073eaac1f4cbf7fd90f3142ae9203404f2889c0e086d07508f04caf675a4d191d52fca30a3108aa61c49e530cf133587ab6"
    },
    {
      "line": 262,
      "relation": "increases",
      "evidence": "In AD, the choroid plexus undergoes many structural changes, such as calcification, fibrosis and AÎ² deposition, all of which can obstruct CSF production.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "source": 70,
      "target": 79,
      "key": "2d1f83f542a76ecc78ef195f8c06e7f6905118b5a320e0d642809118c715ae602101d9fd0de4e9f02f53c6c9600c92e50d805a5c0644f08fb48daa9323fe8531"
    },
    {
      "line": 128,
      "relation": "negativeCorrelation",
      "evidence": "ecifically, AÎ² accumulation into extracellular plaques is marked by decreased CSF levels of AÎ²1â42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "location": {
          "namespace": "GO",
          "name": "extracellular region"
        }
      },
      "object": {
        "location": {
          "namespace": "MESH",
          "name": "Cerebrospinal Fluid"
        }
      },
      "source": 41,
      "target": 32,
      "key": "81ab5063f56b072e4b0eceeba2da5d20ce158ca0f8a2175bd63309ff4898944f283bac6fd97a3c385d6746929c96b2b37d0097b868a2cfc7d9ba5fa34c63a3c6"
    },
    {
      "line": 71,
      "relation": "decreases",
      "evidence": "Soluble AÎ² can be removed from the brain by various clearance systems, including enzymatic degradation and cellular uptake, transport across the bloodâbrain barrier (BBB) and bloodâcerebrospinal fluid barrier (BCSFB), interstitial fluid (ISF) bulk flow, and cerebro- spinal fluid (CSF) absorption into the circulatory and lymphatic systems.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 20,
      "target": 3,
      "key": "cfdb7342329973ca188cc92c3c89421648c409b9bc6825bb97234fa5678b210057665d19715a30efd8407af04afadd1106f134d0ab7be5b670c70529dd1a7146"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "In the early 2000s, mouse studies demonstrated that the majority (75%) of extracellular AÎ² (eAÎ²) is cleared by the BBB, with only a minority (10%) being cleared by ISF bulk flow.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "extracellular region"
        }
      },
      "source": 5,
      "target": 33,
      "key": "817deda339d80193c1d223c51e3d438e5867f31cdb70cefe7bf52f7854ab725b45ff4d70841d2e8ec414d39868f2f1305cbc489770fbfbcb7e6e10f50fd3f232"
    },
    {
      "line": 232,
      "relation": "association",
      "evidence": "Third, ApoE4 is also associated with lower antioxidant activity than other ApoE isoforms,154,155 and it mediates BBB breakdown through a proinflammatory pathway involving cyclophilin A in pericytes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 5,
      "target": 52,
      "key": "5a4bccc2c36372c1762a904021b823f42e5919b88e084a222b7463e4db08460f57612785b4b493e44cc8b3532802f8dfffa7a4cb23452dd658be122e2cf34dcf"
    },
    {
      "line": 78,
      "relation": "decreases",
      "evidence": "In the early 2000s, mouse studies demonstrated that the majority (75%) of extracellular AÎ² (eAÎ²) is cleared by the BBB, with only a minority (10%) being cleared by ISF bulk flow.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "extracellular region"
        }
      },
      "source": 9,
      "target": 33,
      "key": "467b699d04544b731007f926661a0a3577ac6b987abac066c935d6786a11941768cf4a1de17e37b368f2691ab9cadd3f97909e2a6fa0ab2f85d7b4d683c3fae5"
    },
    {
      "line": 81,
      "relation": "decreases",
      "evidence": "However, two-photon imaging studies from the past few years have suggested that ISF bulk flowâfacilitated by astroglial aquaporin-4 (AQP4) channels and named the glymphatic (glial + lymphatic) systemâcontributes to a larger portion of eAÎ² clearance than previously thought.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "extracellular region"
        }
      },
      "source": 42,
      "target": 33,
      "key": "8d996bfb8cd0031225d2ed5d67fb10cc28002d7da88bb07c84a76b930f26a86075548094b6b178a08aabaf11abaacfb1a4ef0bb334091c492612c02267262d45"
    },
    {
      "line": 87,
      "relation": "association",
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 29,
      "target": 70,
      "key": "6fe51955973315a812c2974ea4cd33655b47621b91f36d4002a2846b2834b61975a14f8d83264a98bb43eb565ccc92d73da66946ee9359163ea7e5fce34926a9"
    },
    {
      "relation": "hasVariant",
      "source": 28,
      "target": 29,
      "key": "a2b8b0f059845e4ae4e318598e7fcf54e0cf135333ca9ad300e19ae7be549302b6e14013807e0f5fd2f00d2429f3ab759d5beb8aad79ee3abf084f13d8dd760d"
    },
    {
      "line": 88,
      "relation": "association",
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 31,
      "target": 70,
      "key": "a55215c6186ca5062612194627c1392f180ec2da7e0b5771446648ca59963e23d140bb8fa8ed72948abd9d596525475852e757a029cab3d105b48f505322c922"
    },
    {
      "relation": "hasVariant",
      "source": 30,
      "target": 31,
      "key": "43416f5c5310de2b659e93c7863fe176804d95e6ddd716ed0f1bee2679cd4624d1cf8565c96a9c8b3acf2fd5147198b913620a3e24e265c52058c84f9a5f5713"
    },
    {
      "line": 89,
      "relation": "association",
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 27,
      "target": 70,
      "key": "84775633f80289fc9c3302e13e13efb9a2c872eb8c56d0aafe89e567d0fa1b4fa398828d4347f5fec6b0ad60c84c504c7ef10dad39b6ddf5ee2c04200f83c728"
    },
    {
      "relation": "hasVariant",
      "source": 26,
      "target": 27,
      "key": "f1813f708385bd7ca9d6d7aa2a0e30e78c35478c9e91d7a97338422b4e47578afb15b950ca60c0fed3f910b20817212a5009476f193d0a207a85469d7e62aeca"
    },
    {
      "line": 92,
      "relation": "association",
      "evidence": "Various factors have been reported to positively and negatively modulate the risk of LOAD. Specifically, the greatest overall risk factor for LOAD is ageing;",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 78,
      "target": 70,
      "key": "dd57faf2ee4b90670460eade01434dac6f8e8f1214139b3680f3af43cf65825337cf0b3966593fc065d8d09a530658c1d793cc3e9292ee6f59bb64aa63225823"
    },
    {
      "line": 257,
      "relation": "decreases",
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 78,
      "target": 8,
      "key": "1eee0846652cca5696c0b53137a859171d66015c7df74efc277d3f40284a7c31a263fb5aecbf026d15b45649edf303fba280afbd6a7a7a4304a17f685f84a79b"
    },
    {
      "line": 95,
      "relation": "association",
      "evidence": "The strongest identified genetic risk factor for LOAD is the apolipoprotein E (APOE) Îµ4 allele (APOE*Îµ4),",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 34,
      "target": 70,
      "key": "3d1b19276d94381e5432e3acf8618799085417ad4279d27db68f736e991ba5685e9b058ae144eba9f32e8a66654281a57d1a3e85885644335d54a88145794047"
    },
    {
      "line": 231,
      "relation": "regulates",
      "evidence": "Third, ApoE4 is also associated with lower antioxidant activity than other ApoE isoforms,154,155 and it mediates BBB breakdown through a proinflammatory pathway involving cyclophilin A in pericytes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 34,
      "target": 5,
      "key": "0ea191e7ce11573f23b5406490c61c36d40a20b90623ed8217cae4ee09526a4da3d08b381a6ece6e2eb9b942d0c18cf6d62570930457107a95f6623be346cc32"
    },
    {
      "line": 241,
      "relation": "decreases",
      "evidence": "The pres- ence of ApoE4 is associated with reduced perivascular drainage of AÎ²,161 which in turn is linked to deposition of immune complexes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 34,
      "target": 23,
      "key": "88065ce7e24437a8767824baa68a48b57e2952db254d0dba1d74bef473edeb9b962548f3d6ea4668dff1b65ab6092b8d673f9c8b7ffb2605a3c9d7b96ed6f6ea"
    },
    {
      "line": 98,
      "relation": "association",
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2),27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).28,29",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 53,
      "target": 70,
      "key": "8af41c61cc6490c2fc3a8750181646eb8ff3c311a046696105f550f87ccb1449a49acc650a20fd3e61716606b71bbdf4096937e862cdc1fc3beee1980edd84aa"
    },
    {
      "line": 99,
      "relation": "association",
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2),27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).28,29",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 44,
      "target": 70,
      "key": "0bb3d61fee62f60aa866b0445a78c19e5accde7d4c45ac34b57079a239d3bb6e905b7d74fe32d6ebb1730da448cc7ba39311085a678dddb12b5dadb3cf26e65b"
    },
    {
      "line": 100,
      "relation": "association",
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2),27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).28,29",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 51,
      "target": 70,
      "key": "63401ee77c75838db97a7899e3a31ec81280592cf6a647dffcc05eeb96d583eb3eb4d60a8fe1aa623a627a339a88d2383806410a6567c3b356a2e52eb1f1fb8f"
    },
    {
      "line": 103,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 73,
      "target": 70,
      "key": "e5824dc580b0fd12cddffe0d03d101136feb0f5b2c92c2334dc694c67e3700fe6430ce4b713e77fa21ab2289436f03bdb8a3ea103a5f86cb565fee661f33d470"
    },
    {
      "line": 104,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 75,
      "target": 70,
      "key": "823cfa0ea756a5c99d379567d81b270637dd0492360820076bf3ae2aece95aedaad7314a7f9a990954ef90b0ea3a65486e5112a34c7c1421a76382899284fe32"
    },
    {
      "line": 105,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 80,
      "target": 70,
      "key": "36311057ae167dccfc997c29a4f6f0628bd61437396a80ce3eb53205a7a33854ff9b1c7ef5ff6727d6d53b0c364c440c799acfbc6ac14183e1ab6db5f68770d4"
    },
    {
      "line": 106,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 74,
      "target": 70,
      "key": "edf61a397cfa982b604017bdf7600b9cadaead7eb5e332bbe924effa3a9efbc5854fb07838bba62beef0eeae7db3ff7bb59a46a50992933064bd50273ff1ce6a"
    },
    {
      "line": 107,
      "relation": "association",
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 77,
      "target": 70,
      "key": "b1e8d710227f4888a866c96830e79db68f847c8d497de78b363031045e35bb8f65ad5d951b070b90af77b249c525e61242762de9c495d753083334e89854e13b"
    },
    {
      "line": 254,
      "relation": "increases",
      "evidence": "These findings might partly explain why sleep impairment increases the risk of AD",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 77,
      "target": 70,
      "key": "824366aa465a615ac99c44deaae27187650fd13d92c7962214e8cf25223d2ca32d793fa46194b9cfa7061eba31829286a88eeb30da1ccc26e7235ce4e597e74e"
    },
    {
      "line": 110,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 76,
      "target": 70,
      "key": "d4faeb9bbd12212f4d715a1a4a240483d20fa5e096eb9d89ac13b9f459c8c339ac50227b2b2690779cb0462a1c450a6b54b0fc6deaa23b2f355c614c63ef0917"
    },
    {
      "line": 111,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 11,
      "target": 70,
      "key": "b54e5d5bf88db55ecfd6d9ec22e0d54e6d4acd982a796eaa12b31e399852fa4249453cd462cc3d2745752656fa8f7ba39269e02c14b64e52679a8ff26b7bccf6"
    },
    {
      "line": 112,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 6,
      "target": 70,
      "key": "a8bd1268256e8ceb2141ca8d11ee7f3d0b1cf77373cddc12aca8647ebc80af7ad9152d75b5943d4442ece3beea91cec908783fed1b25b48bf182bd39a45aef88"
    },
    {
      "line": 113,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 7,
      "target": 70,
      "key": "11d3c2fbeaa54e46ccc6365c4f8b0278f66fda7a97d5a019f400fb5cd6cbace082a55fb1e78fb164e383564450fe01c993f1b49e24b2d274f1ad3da75abfd6c7"
    },
    {
      "line": 114,
      "relation": "association",
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 12,
      "target": 70,
      "key": "a255a83edaf46e0e1484106198eabd2ec6b7a93579860242a711792382ad1e6f84aae7474309e183c7aac1eb9cb787c5a5a7154b1dd8e69282d8714454ca1094"
    },
    {
      "line": 128,
      "relation": "negativeCorrelation",
      "evidence": "ecifically, AÎ² accumulation into extracellular plaques is marked by decreased CSF levels of AÎ²1â42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "location": {
          "namespace": "MESH",
          "name": "Cerebrospinal Fluid"
        }
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "extracellular region"
        }
      },
      "source": 32,
      "target": 41,
      "key": "52678f2932831b2778ad6b5871fc80117ddefb050197d91a78aca677fe03ad9621d0a67f4153304d4608607c4b87f86507af027b24fe9b5977d461faf7a8c241"
    },
    {
      "line": 129,
      "relation": "positiveCorrelation",
      "evidence": "ecifically, AÎ² accumulation into extracellular plaques is marked by decreased CSF levels of AÎ²1â42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "location": {
          "namespace": "MESH",
          "name": "Neurofibrillary Tangles"
        }
      },
      "object": {
        "location": {
          "namespace": "MESH",
          "name": "Cerebrospinal Fluid"
        }
      },
      "source": 48,
      "target": 48,
      "key": "25fde49a27b96dfba24b25fbdf4db7ca27b08c808fe8fb508852c228107d235bb7c46102b577fea870a22dea3ee3fd2c0ac1c80501e324e549964d7622a84b13"
    },
    {
      "line": 129,
      "relation": "positiveCorrelation",
      "evidence": "ecifically, AÎ² accumulation into extracellular plaques is marked by decreased CSF levels of AÎ²1â42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "location": {
          "namespace": "MESH",
          "name": "Cerebrospinal Fluid"
        }
      },
      "object": {
        "location": {
          "namespace": "MESH",
          "name": "Neurofibrillary Tangles"
        }
      },
      "source": 48,
      "target": 48,
      "key": "da412ad6b392c51104b3ad462e505fdbf487694c3dd92e5aa67a083fa491a760aa0ce1130b8d1f7c10e6bff60a1f3b6e2972e53707c291116fbcde7db1a4e0e1"
    },
    {
      "relation": "hasVariant",
      "source": 48,
      "target": 49,
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48"
    },
    {
      "line": 133,
      "relation": "decreases",
      "evidence": "Extracellular degradation of ISF proteins mainly consists of degradation by proteases expressed and secreted by cells such as astrocytes",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 13,
      "target": 41,
      "key": "693d66810a521bf78ea41ceb71387f698002c3e49f587aff6c935e2a97a983fabb554e90124ba60e0d09c635f2db2bd80131c119dc92448791b7cecf33a14f34"
    },
    {
      "line": 173,
      "relation": "decreases",
      "evidence": " Specifically, ISF AÎ² can be taken up by microglia and astrocytes, whereas perivascular AÎ² can be degraded by vascular smooth muscle cells, perivascular macrophages, and astrocytes",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "MESH",
          "name": "Extracellular Fluid"
        }
      },
      "source": 13,
      "target": 2,
      "key": "85b3b4d0e191c499a4a99213713c6dd267ae31f90e670835199fafa28239802a63bd9ca06fb0eb614d52d2252d34711d20d4fbb6cda1a6a0bc5ca2a6658cf671"
    },
    {
      "line": 136,
      "relation": "decreases",
      "evidence": "Intracellular degradation of proteins occurs via the ubiquitinâ proteasome pathway, the autophagyâlysosome pathway, and the endosomeâlysosome pathway.56",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 67,
      "target": 41,
      "key": "240465c36291eb5ff4294d2ab29d4f69e6f207ed672bdaf6ebf76564a60c92c37dc9d39bdc0b13cd12c37cd320d3306f7b936bbeac8cacb0ae46f9aaa4e8716d"
    },
    {
      "line": 156,
      "relation": "decreases",
      "evidence": "Intracellular AÎ² (iAÎ²) can be degraded by proteasomes via the ubiquitinâproteasome pathway in neurons,116 lyso- somal cathepsin enzymes,117 proteases (such as insulin- degrading enzyme, a thiol metalloendopeptidase that degrades monomeric AÎ²) and insulin.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 67,
      "target": 2,
      "key": "9bb9f57d8f481f750a3bdc752ef00f32c001cb78a0390d3c6f030b311939a77432516aea66faa689bd3a9a18b38ad770a42b76a00ebe3b67177897941aaf7854"
    },
    {
      "line": 266,
      "relation": "decreases",
      "evidence": "Tau is mainly cleared through intracellular degrada- tion by lysosomes via the autophagyâlysosome pathway, and by proteasomes via the ubiquitinâproteasome pathway.202 ",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "source": 67,
      "target": 48,
      "key": "b9a872483e81e7d2dd3bd0fc20386f37954f38ee12ba1d651961ccf19951fa12b1b96778a51cc2eb448b15ef2ca6178ca6b8c283dbd279adaa67a9da77824ffc"
    },
    {
      "line": 137,
      "relation": "decreases",
      "evidence": "Intracellular degradation of proteins occurs via the ubiquitinâ proteasome pathway, the autophagyâlysosome pathway, and the endosomeâlysosome pathway.56",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 21,
      "target": 41,
      "key": "72b00df9099377094f5f44887a4f87475a160986e4d62da63f43575f22df1f8703bd84562df92592d856ccc31ad4f49c9ff7c875fa8c5b34d65121f54a2f1319"
    },
    {
      "relation": "hasComponent",
      "source": 25,
      "target": 15,
      "key": "12f2f7129ddf4a683b6ccf317ee037d2ceaaa643edfbc2bdd42db33a1ca68dca6f39775985b9e52760d124bbec395aed2c55a8004b32062c343925104de6fbe7"
    },
    {
      "relation": "hasComponent",
      "source": 25,
      "target": 17,
      "key": "ae105e874aa1154f2157811d229b994a9bc72d21340c928bd5c13d7689f3045081399a74023eee45e5f5c7d82e3cd4a34eda4cfef47ec48eaf5f29c42afa2ce4"
    },
    {
      "line": 138,
      "relation": "decreases",
      "evidence": "Intracellular degradation of proteins occurs via the ubiquitinâ proteasome pathway, the autophagyâlysosome pathway, and the endosomeâlysosome pathway.56",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 25,
      "target": 41,
      "key": "680af8bcd8a03d0303b0746fd6be2f30c0c731c0ef1449764abef15f6552bd9274913d582448227d1ead69ba997edf897bda6d4d561f3a3339734e204cf17c92"
    },
    {
      "line": 141,
      "relation": "association",
      "evidence": "Given the size of AD-related proteins, mono- meric AÎ²1-40, AÎ²1-42 and tau, should be able to pass freely through astrocytic endfeet clefts at the glial barrier.72",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 0,
      "target": 70,
      "key": "d27f8427c82f4c8f3d8d1969c0ead4fef843b4ad4458f6f1b5cab7dafef92cdbb66034039870a6760aa6d9bc44890c36b34dd67b8ea3a8a397f8ad972c49332f"
    },
    {
      "line": 151,
      "relation": "isA",
      "evidence": "The most common soluble monomeric isoforms of AÎ² are AÎ²1-40 (<80%), AÎ²1-38 (<20%) and AÎ²1-42 (10%).105 AÎ²1-40 is prone to be deposited in the vasculature, as seen in CAA.15,106 ",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 0,
      "target": 2,
      "key": "1d87ed5c97b0ecdcec5c161337ce6c02b9aa333a7708043a61e7d2db396decf0c248e1ebc6ad47ebc3a6099708596cd89c72ae7f620d1535c45f018dd75249d6"
    },
    {
      "line": 142,
      "relation": "association",
      "evidence": "Given the size of AD-related proteins, mono- meric AÎ²1-40, AÎ²1-42 and tau, should be able to pass freely through astrocytic endfeet clefts at the glial barrier.72",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 1,
      "target": 70,
      "key": "677089232ccc38b01196b316c97489d1f7e2aa2ec9d9321d978cf24b4dd4ef395ae8c0df007be9710f8a3a38d3bde85609dbb092916cef91ae0f18ecba9e6539"
    },
    {
      "line": 152,
      "relation": "isA",
      "evidence": "The most common soluble monomeric isoforms of AÎ² are AÎ²1-40 (<80%), AÎ²1-38 (<20%) and AÎ²1-42 (10%).105 AÎ²1-40 is prone to be deposited in the vasculature, as seen in CAA.15,106 ",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 1,
      "target": 2,
      "key": "1f9775e7a5868294a72e121e524368fdbf2f171b22bce26abddb0cd685c95eba3e5873522e8682e53d50346c9af87e2ee0dd73bb6dbd012363e2256524329dce"
    },
    {
      "line": 145,
      "relation": "increases",
      "evidence": "APP is cleaved by Î±-secretase, which precludes forma- tion of AÎ², and the resulting carboxy-terminal fragment is then cleaved by Î³-secretase.103 The resulting products do not aggregate.104",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 54,
      "target": 2,
      "key": "81581729fc72eea8bdf012666e3ba972959e6a3f6f00bf9bf4fe07fc00f7bb39db5971905d15055f034f1e6fbb2d215120e5049c81775ac9b17e6c4d98bdb520"
    },
    {
      "line": 202,
      "relation": "association",
      "evidence": "In addition, insulin-degrading enzyme has been proposed to have a role in AÎ² clearance through the BBB, which might explain why BBB clearance is sensitive to insulin.144",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 2,
      "target": 16,
      "key": "199d30c8849acd83ca1cc99749a09dd1f2565251b922d2ce4703ff26137a80bd2944012f99c6d51d5d16ba0b5d154a3f4dd4179c3ff7b55a483e0365d4d25950"
    },
    {
      "line": 238,
      "relation": "association",
      "evidence": "AÎ² is cleared along perivascular drainage pathways.83 In both AD44,160 and CAA44 (commonly associated with AD84), perivascular drainage of AÎ² is impaired.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 2,
      "target": 23,
      "key": "b1b8fb624dc9e0886940a5c26504af53e02a1bdd8829f1fee9e9770ea3a5246a9a5da8427ee92c8fc7e4a66ebf30e7cbce4ba7a72a4a8e342b5e2774cef32d19"
    },
    {
      "line": 148,
      "relation": "increases",
      "evidence": "If APP is first cleaved by Î²-secretase 1 (also known as BACE1) instead of Î±-secretase, the subsequent Î³-secretase cleavage will result in soluble monomeric AÎ².",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 43,
      "target": 3,
      "key": "f70f5d3bd7853ed2004eb28cb676c60e3e41b156ea644a1e91ae6b3500aaf70fad9e0fb0eadb3338313d81d6ec444b63878abb7224dd7ca1a67b8400eedbf4c7"
    },
    {
      "line": 153,
      "relation": "isA",
      "evidence": "The most common soluble monomeric isoforms of AÎ² are AÎ²1-40 (<80%), AÎ²1-38 (<20%) and AÎ²1-42 (10%).105 AÎ²1-40 is prone to be deposited in the vasculature, as seen in CAA.15,106 ",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 4,
      "target": 2,
      "key": "16fa4e13583fb3a4743c9e6ec1b723fb8e61281b2d3c5924d024e16f6f5f36e437d4fb65d245ae85fd3281e112f72dc21d12ecbcbe301a86d25798407415fcd0"
    },
    {
      "line": 157,
      "relation": "decreases",
      "evidence": "Intracellular AÎ² (iAÎ²) can be degraded by proteasomes via the ubiquitinâproteasome pathway in neurons,116 lyso- somal cathepsin enzymes,117 proteases (such as insulin- degrading enzyme, a thiol metalloendopeptidase that degrades monomeric AÎ²) and insulin.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 63,
      "target": 2,
      "key": "379c1bba72831d51aef841707513bc3b7d65d8925af688de6048482e36131fe9f6d3955d6abc6e2262730999e66d6573f86e34c1ae17ba49f7ade2d100c15496"
    },
    {
      "line": 160,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 66,
      "target": 2,
      "key": "f8bf2a662703ceaf90407030b9975bd71fad892b07b0a593fb31dd4f68021446ad2c5635e5cb0b393a6fb3a009351aa373dfc2184c1f0fd0d18d30b74045a809"
    },
    {
      "line": 161,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 60,
      "target": 2,
      "key": "5cabef2bff39eccb65a41cddc919a280db89833ffd4d989c6293eedbcf89062c70b722dcefa1bfc220afce3f9f5abeb4e6036bc8131451f13d1d7f3e18e9984b"
    },
    {
      "line": 162,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 58,
      "target": 2,
      "key": "77026918dad6c6aace0b7ffd2704e5a8e03f5cf8248e75ff5f1dac2f6a2cc7172a203945e18e15b5bfebe778ac7331a0a36ec711c84bfe847126ca1829042f2e"
    },
    {
      "line": 163,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 59,
      "target": 2,
      "key": "762cb7c1c31536bbd0649d23f89383b18871d91b2539b787b6c464eb74a2ce3c8e71551f98f715ccead77090df11c0f568cb811525700751127cdf0c777c05ff"
    },
    {
      "line": 164,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 57,
      "target": 2,
      "key": "5a88beb71aabc8458f4f5d5abbb16225a6876de8bf92b5c8c76f93532f6d04801ea21716d267ff3c7c4904ced5b555cbb9412204bcfb18c869602fd2a3bf98ed"
    },
    {
      "line": 165,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 56,
      "target": 2,
      "key": "36bbc6fdee1108252dcee73e67486cf7bd7f4c3b43b47627a8ace7cacef3d9817e5f129157a3afd9907b21a36891133520ddc323213cb714c3f24d1bacd46c18"
    },
    {
      "line": 166,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 61,
      "target": 2,
      "key": "60a320aa70184db8c54cd38c1784383dce9381b5c64507d0a0ddea74da8af159b9ae17229d3bf01c0f2a71aa92a1b42fa79d019cce8830c0c5ebc1ee36d65a98"
    },
    {
      "line": 167,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 64,
      "target": 2,
      "key": "370de1ddf57c90b7f71a9aa1ca828c6970f06086dd8cb9df1ae197a56422ed6b056e420244f9e6eff6b63c2a5b239704d4947c2c3807d2eb3f4601527e2d4db4"
    },
    {
      "line": 168,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 38,
      "target": 2,
      "key": "1e912336d1d20a9ac212564b2a5f5df5df83fee7758a187ab59ed83a16e029d4da540d85873e73c889e76b0e21809cf3139078e3ba1700ca0bee0b7cc161346a"
    },
    {
      "line": 169,
      "relation": "decreases",
      "evidence": " Extracellular AÎ² can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the AÎ² monomers AÎ²1-40 and AÎ²1-42, and AÎ² oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        }
      },
      "source": 45,
      "target": 2,
      "key": "94ff80ad5faf658dcfae7a05a15aedea4362af3a6d7d71a283271c2d734c13b3cc97c23c3582a7f000ffb5d4b70790b0a1abba1aaf929e0d445fe70536ae654e"
    },
    {
      "line": 172,
      "relation": "decreases",
      "evidence": " Specifically, ISF AÎ² can be taken up by microglia and astrocytes, whereas perivascular AÎ² can be degraded by vascular smooth muscle cells, perivascular macrophages, and astrocytes",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "object": {
        "location": {
          "namespace": "MESH",
          "name": "Extracellular Fluid"
        }
      },
      "source": 18,
      "target": 2,
      "key": "f39c1843530a19ef1ef69600e5074750c594780d6e57f32d2c8102c9fdfa4c4a7c1a74caace04b2ef1f37fa6879609b1ef877f99bc6bca0de052c4d8ba8d32b6"
    },
    {
      "line": 174,
      "relation": "decreases",
      "evidence": " Specifically, ISF AÎ² can be taken up by microglia and astrocytes, whereas perivascular AÎ² can be degraded by vascular smooth muscle cells, perivascular macrophages, and astrocytes",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "source": 10,
      "target": 2,
      "key": "a9e55428b4115e27b1346f55344aee8c7c7b8789ab660b81087500a18e2d768c3d9e580702b10312919b8ae945a1dcca9d87d861a3b0c07e47e728847dfd563c"
    },
    {
      "line": 184,
      "relation": "increases",
      "evidence": "Second, both AÎ² and insulin are ligands that compete for degradation by insulin-degrading enzyme; thus, hyper- insulinaemia can reduce clearance of AÎ², which might partly explain the link between type 2 diabetes mellitus and AD.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 16,
      "target": 2,
      "key": "c871950c1e21b468f074a8a1018e906da937a304af1079adaa2e90f9e0d43e6f41885b8759e99250c622874ed3eaf2ddfedabf6653d65f961e82e54db40e2bad"
    },
    {
      "line": 202,
      "relation": "association",
      "evidence": "In addition, insulin-degrading enzyme has been proposed to have a role in AÎ² clearance through the BBB, which might explain why BBB clearance is sensitive to insulin.144",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 16,
      "target": 2,
      "key": "2b3795fa7c0d470dc95be834255ad9517a9b359f89ec27d7f9e89b1b366fa7b1c29416d590b309bd09ded78ff8593ff7d290c86dc3abf5fc814bc4c10232a39f"
    },
    {
      "line": 189,
      "relation": "increases",
      "evidence": "Some evidence suggests that LRP1 is the main transporter for AÎ² efflux at the BBB, whereas other studies have demonstrated its role to be quite minor.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Translocation"
      },
      "source": 46,
      "target": 2,
      "key": "632ab470f85266956b358c9521649b9630f0bebab9204d86a839548a866fe520c077c087b91c133af9d7e36d342bd47348e20b34ac1ea8ca85f2638b6803def5"
    },
    {
      "line": 210,
      "relation": "increases",
      "evidence": "Specifically, local soluble AÎ² is transferred from the interstitium to the brain by LDL receptor (LDLR) family members such as LRP1, and ATP-binding cassette transporters (ABC transporters).",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "MESH",
            "name": "Nephritis, Interstitial"
          },
          "toLoc": {
            "namespace": "MESH",
            "name": "Brain"
          }
        }
      },
      "source": 46,
      "target": 2,
      "key": "c986e58801148b344ef80c1bd4b6f6b0fe9385ecf19c4312d1a7fba2bd2b3dfa92148e697d8297dd40e4c660395c4681f67c28137c92e05db0e8c7f0a09be57a"
    },
    {
      "line": 224,
      "relation": "increases",
      "evidence": "ApoE is a cholesterol transporter that competes with AÎ² for efflux by LRP1 from the interstitium into the circula- tion;",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Translocation"
      },
      "source": 46,
      "target": 2,
      "key": "9cf96ffe761049b01a18ad73fd56858be4b8630471e5e80dc21f1e8e7c495fdd222f551d54c8a2e0f272cd838e2e67826ffeae64989e6b883c73ceab0f265ccf"
    },
    {
      "line": 192,
      "relation": "increases",
      "evidence": "The main ABC transporter responsible for AÎ² efflux is ABCB1 (also known as P-glycoprotein 1 or MDR1),which directly exports AÎ² into the circulation.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Translocation"
      },
      "source": 37,
      "target": 2,
      "key": "a575d69fc07cda19dde8925523f154980a5ff8b579465f6802163821f1105792db623a8dbb172672c42a1ed3af7fe7d3fde2261c3a8569f2bec233a0562092d6"
    },
    {
      "line": 213,
      "relation": "increases",
      "evidence": "The main ABC transporter responsible for AÎ² efflux is ABCB1 (also known as P-glycoprotein 1 or MDR1), which directly exports AÎ² into the circulation. ",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Translocation"
      },
      "source": 37,
      "target": 2,
      "key": "5a9f5f943a9785949df862dafe1025bfa5890f0c5fa16c304c3d4d4055ccf3bf9f1c4cf94356568d97640bf0761129ff428a52113666014b42db23d06070bfb2"
    },
    {
      "line": 195,
      "relation": "regulates",
      "evidence": "which is located on the abluminal side of the brain endo- thelium,140 does not directly bind and extrude AÎ²,141 but mediates AÎ² clearance in an ApoE-dependent manner.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 40,
      "target": 2,
      "key": "f2d231f52041d607505f264f080ecc8d9e1d8c3319389ac703ed97ac28538056c06386ea83e8fbbba3ad3f83a2ad0e609080e5c67c8bb7b0df982a12a7e5e6d7"
    },
    {
      "line": 225,
      "relation": "decreases",
      "evidence": "ApoE is a cholesterol transporter that competes with AÎ² for efflux by LRP1 from the interstitium into the circula- tion;",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 40,
      "target": 2,
      "key": "9493eb326ab56f91f1fc59ebfb6d8421d5348b8a4b17ee13abab1c5d595d5f5c5a54f9d069b4e4d3844d889c279005d8f7589b6043576b4938322f7d3734c49f"
    },
    {
      "line": 228,
      "relation": "regulates",
      "evidence": " competition for shared receptors is the primary mechanism by which ApoE mediates AÎ² clearance",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 40,
      "target": 2,
      "key": "161d28ba502b1f91155cfec1a7f7843c6a46057592676dd7709e3ba0dabb18bbd24c582b07ec4f6e3eb25d96e0a9966bbe15b33175d9f3e0482c2cdbfcaa932c"
    },
    {
      "line": 198,
      "relation": "regulates",
      "evidence": "Clearance of AÎ² through the BBB is also medi- ated by Î±2-macroglobulin (Î±2M),14 and LDLR-related protein 2 (LRP2, also known as megalin) when LRP2 forms a complex with clusterin (also known as ApoJ).",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 36,
      "target": 2,
      "key": "b01fed3af368fae6596d36e23748ec33fa9ba35ba30ef7a413bf08d9392f40b640f39123f93d7e7b5f35a821a7644ce16bec296002a35e0e1334e86206fb2348"
    },
    {
      "line": 199,
      "relation": "regulates",
      "evidence": "Clearance of AÎ² through the BBB is also medi- ated by Î±2-macroglobulin (Î±2M),14 and LDLR-related protein 2 (LRP2, also known as megalin) when LRP2 forms a complex with clusterin (also known as ApoJ).",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 47,
      "target": 2,
      "key": "78575ab21b8fc85d46b74a1fa144c2813ae437062d563ec06e4ff01bd602962a5b5faa5234ecb50ac63ac5f895101dcd83db5b207cb948d0de09d1408dc127c5"
    },
    {
      "line": 205,
      "relation": "increases",
      "evidence": "Free AÎ² can be transported from the circulation into the interstitium via RAGE (advanced glycosylation end product-specific receptor).",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Translocation"
      },
      "source": 39,
      "target": 2,
      "key": "6a9bb4b1d152a71f260e22b45cba035d313277c22dd0f4b5f994b16833e6444737e0d99f8943bafd91d0a97cbab6de7e44b7338836457cc8c350498661b49199"
    },
    {
      "line": 221,
      "relation": "increases",
      "evidence": "Inflammation, a common feature of AD, can affect ligand affinity by making the pH more acidic, which promotes hyperphosphorylation of tau and induces conforma- tional changes in AÎ² that hinder its clearance.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 81,
      "target": 49,
      "key": "eafd7bc292469d95acbf40823e73fba99c38794a7cf8bc5be67e1382bf15fff24a0b6846486f2de971db69eca17ee7674e76818d0927be95ae1d1f253e5edd64"
    },
    {
      "line": 270,
      "relation": "decreases",
      "evidence": "Phosphorylation of tau by protein kinase A increases its resistance to degradation by calpain",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 49,
      "target": 62,
      "key": "7e1cc6f7d7860baee923208524956d64e73629db36eeef21cd9559dcbd963c91f6f90b90e5e6d9c0d83250fbc0a46a40ad0edc106edde4d27b687d2353ee5dbe"
    },
    {
      "line": 232,
      "relation": "association",
      "evidence": "Third, ApoE4 is also associated with lower antioxidant activity than other ApoE isoforms,154,155 and it mediates BBB breakdown through a proinflammatory pathway involving cyclophilin A in pericytes.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 52,
      "target": 5,
      "key": "c801f5d60aeda013e4a0aa4ec705f5d0d3c3cc924d46bc64db1ebc3b924a6eb5708358428b9339f39c92b66ed99c33e27825b895917be3411350efbaccacd193"
    },
    {
      "line": 235,
      "relation": "increases",
      "evidence": "These findings are in line with evidence suggesting that increased oxi- dative stress157 and loss of vascular integrity contribute to ageing158 and AD,159 as demonstrated by accelerated breakdown of the BBB and the neurovascular unit.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 24,
      "target": 78,
      "key": "38698ea32212f1c59a0c97abd1268ea7048da7d18ebe26f3ef4fa0e5d20ca5042ff0ac5dae4e9ca3eb374a9ce145dd2452e3470ef603b406930637f7b34d31be"
    },
    {
      "line": 238,
      "relation": "association",
      "evidence": "AÎ² is cleared along perivascular drainage pathways.83 In both AD44,160 and CAA44 (commonly associated with AD84), perivascular drainage of AÎ² is impaired.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 23,
      "target": 2,
      "key": "b6b962eff021d263eab52655cc2cadc9bc59b58ebb72c0c600442e25ec5f3244517aee9461693df2c4adf0b8ebcf6d19962dfd249108aab467e7bbe92978e13b"
    },
    {
      "line": 244,
      "relation": "increases",
      "evidence": "Of note, a high-fat prenatal maternal diet has recently been reported to result in a failure of AÎ² clearance along cerebrovascular basement membranes. ",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 69,
      "target": 2,
      "key": "9d4f7a72843db3fb469d93af6b6c3b8e09ab0d33b32aca48c688c7076a79d4d0d7ba0c3c3389d2d6f8eaa428cf33468b204455cdb0040a6ca42f307043ad7266"
    },
    {
      "line": 247,
      "relation": "decreases",
      "evidence": "Recent mouse studies suggest that the AQP4-dependent glymphatic pathway is an important clearance system for driving the removal of soluble AÎ² from the interstitium.",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 68,
      "target": 2,
      "key": "0ce370af04b309907ea9d33d409707210761e91f36aa672ec5b2f5d267065ff036183ab2c6e3c8f221d8db0acb199885a43a7f36e685b1ef6e8454f411897f7e"
    },
    {
      "line": 250,
      "relation": "increases",
      "evidence": "Thus, sleep could indirectly increase BBB clearance of AÎ² through increased glymphatic bulk flow, but it might also directly increase clearance through the BBB via various mechanisms, such as molecular changes (for example, upregulated LRP1), as seen with AD-protective physical and cognitive activity in mice.1",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 82,
      "target": 5,
      "key": "5cb61e35bab8e86cf739a299c95db0ebf63b51791d931892fa7a5d601e85520b63bbfd24f2bff1c0661f4058aa41ea077b934b0a82a034d7bc7ee3af9b1285a8"
    },
    {
      "line": 251,
      "relation": "increases",
      "evidence": "Thus, sleep could indirectly increase BBB clearance of AÎ² through increased glymphatic bulk flow, but it might also directly increase clearance through the BBB via various mechanisms, such as molecular changes (for example, upregulated LRP1), as seen with AD-protective physical and cognitive activity in mice.1",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "source": 82,
      "target": 22,
      "key": "d584870235db1e4bcbcfd7acb0aaca92427e80170a369761b7f9dde671f972babb07dcf374091ea12fbade84447b4958222231dd7faec311bbe3b5938a1a1615"
    },
    {
      "line": 265,
      "relation": "decreases",
      "evidence": "Tau is mainly cleared through intracellular degrada- tion by lysosomes via the autophagyâlysosome pathway, and by proteasomes via the ubiquitinâproteasome pathway.202 ",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 65,
      "target": 48,
      "key": "93452464ddde1f4703552bf1fb569f957680157cc4399c989b91c3bec3701c2e1822465570b5c95d92f6ee87d97bf6770d4dd2412686ef005812e2d8cc101b17"
    },
    {
      "line": 269,
      "relation": "increases",
      "evidence": "Phosphorylation of tau by protein kinase A increases its resistance to degradation by calpain",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "source": 55,
      "target": 49,
      "key": "aa79d8afc1f25faeddbf6ba759ecf8828d54752c7572e85892b767f0b8f1827be5f2985bd8baccfe63c49a0cf1ceebf8a00235f601f542063ecfafecd4152048"
    },
    {
      "line": 271,
      "relation": "decreases",
      "evidence": "Phosphorylation of tau by protein kinase A increases its resistance to degradation by calpain",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 62,
      "target": 48,
      "key": "7019550667fcedd2dc3f2eca12adb7f2f3c66207b9223efe2dea4f65ec6cc26cb9344415b58a1f30944c78a1d68a48d805e5b488dd8c2ea7ef40716a8a14e45b"
    },
    {
      "line": 274,
      "relation": "association",
      "evidence": "These findings support the link between TBI and tau aggre- gation, with resulting neurodegeneration similar to that seen in AD and chronic traumatic encephalopathy",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "source": 71,
      "target": 35,
      "key": "061ee2570c895cde0d7e4ac8b031db2e6b94997548597babf9f29d3525511133adb971c2abe2b94151ed2d9dd169fe21af688f27c551b461eba9d0e77222b9a0"
    },
    {
      "line": 274,
      "relation": "association",
      "evidence": "These findings support the link between TBI and tau aggre- gation, with resulting neurodegeneration similar to that seen in AD and chronic traumatic encephalopathy",
      "citation": {
        "type": "PubMed",
        "reference": "26195256",
        "name": "Nature reviews. Neurology",
        "title": "Clearance systems in the brain-implications for Alzheimer disease.",
        "volume": "11",
        "pages": "457-70",
        "date": "2015-08-01",
        "first": "Tarasoff-Conway JM",
        "last": "de Leon MJ",
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "MÃ©nard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "source": 35,
      "target": 71,
      "key": "4bae277cf6ee0ecd79aaffb6565537e0879719c6a52be93c6cba16a57e6d70bedaf5bc4ca52cdcd0ebd3fddb98ff0f38b9a7d00db2d9bd50c654739a0113f465"
    }
  ]
}